Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial

BACKGROUND: We aimed to assess 24-month outcomes of wearing an organic light-emitting sleep mask as an intervention to treat and prevent progression of non-central diabetic macular oedema. METHODS: CLEOPATRA was a phase 3, single-blind, parallel-group, randomised controlled trial undertaken at 15 op...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivaprasad, Sobha, Vasconcelos, Joana C, Prevost, A Toby, Holmes, Helen, Hykin, Philip, George, Sheena, Murphy, Caroline, Kelly, Joanna, Arden, Geoffrey B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Lancet, Diabetes & Endocrinology 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908782/
https://www.ncbi.nlm.nih.gov/pubmed/29519744
http://dx.doi.org/10.1016/S2213-8587(18)30036-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908782/
https://www.ncbi.nlm.nih.gov/pubmed/29519744
http://dx.doi.org/10.1016/S2213-8587(18)30036-6

Ejemplares similares